BioSpace News Archive

NuCryo Vascular announced that the company has signed a commercialization agreement with Lokai Medical, a specialty distributor of coronary/peripheral and interventional devices, to distribute the PolarCath™ Balloon Dilatation System in the United States.

The National Comprehensive Cancer Network® (NCCN®) has released new treatment guidelines for a group of rare cancers that impact women during pregnancy.

Trans-Hit Bio is pleased to announce today the signing of an exclusive commercial agreement with Maricopa Integrated Health System (MIHS), a public teaching hospital and safety net community system of care, located in Phoenix, Arizona.

An experienced multidisciplinary team joins Pacific Neuroscience Institute to treat psychiatric and neurological conditions including Alzheimer’s disease, depression and anxiety, and to promote healthy brain aging.

Dave Harris is a recently retired principle at PricewaterhouseCoopers (PwC)

60° Pharmaceuticals (60P) announced today the Food and Drug Administration (FDA) approval of ARAKODA™ (tafenoquine) tablets for the prevention of malaria in patients aged 18 years and older.

Transplant Genomics Inc. (TGI) is pleased to announce that Dr. John Friedewald (Northwestern Medicine) and colleagues have published a manuscript titled “Development and Clinical validity of a novel blood-based molecular biomarker for sub-clinical acute rejection following kidney transplant " in the American Journal of Transplantation.

MedX Health Corp. announced that Dr. Trevor Champagne, Clinician in Quality and Innovation at Toronto’s Women’s College Hospital, has joined its Medical Advisory Board.

Cura is on a mission to be the leading provider of premium cannabis oil and hemp oil to the legal U.S. and international markets, and will enter the Canadian market to supply domestic and international channels through this agreement.

Additional surgery centers and office-based locations are scheduled for implementation later this year.